Leptin-regulated endocannabinoids are involved in maintaining food intake (letter – 2001)                                  


Association study of cannabinoid receptor gene (CNR1) alleles and anorexia nervosa: differences between restricting and binging/purging subtypes.                                                      (abst – 2004)


Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa.                                                            (full – 2005)


Lack of association of genetic variants in genes of the endocannabinoid system with anorexia nervosa    (full – 2008)                             


Role of endocannabinoids and their analogues in obesity and eating disorders. (abst – 2008)                                 


Elevated cannabinoid 1 receptor mRNA is linked to eating disorder related behavior and attitudes in females with eating disorders.                                                            (abst – 2009)


Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects.                                                       (abst – 2009)


Medical Marijuana and Anorexia Nervosa                     (news – 2009)


Activity-based anorexia in C57/BL6 mice: effects of the phytocannabinoid, Delta9- tetrahydrocannabinol (THC) and the anandamide analogue, OMDM-2.                                                                 (abst – 2010)


Molecular mechanisms underlying anorexia nervosa: focus on human gene association studies and systems controlling food intake.                                                    (abst – 2010)


A nonsynonymous polymorphism in cannabinoid CB2 receptor gene is associated with eating disorders in humans and food intake is modified in mice by its ligands.

(abst – 2010)           


The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction

(link to PDF – 2011)     


The genetics of eating disorders.              (abst – 2011)


Brain Type 1 Cannabinoid Receptor Availability in Patients with Anorexia and Bulimia Nervosa.            (abst – 2011)         


Functional polymorphism in the GPR55 gene is associated with anorexia nervosa. (abst – 2011)                          


The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia.                                                   (abst – 2011)


Fish oil promotes survival and protects against cognitive decline in severely undernourished mice by normalizing satiety signals.                                                                         (abst – 2011)


Do Deficits in Brain Cannabinoids Contribute to Eating Disorders?

(news – 2011)     


Scientists Link Malfunctions in the Endocannabinoid System to Bulimia and Anorexia (news – 2011)  bulimia-and-anorexia-


The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia.        (full – 2012)


The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia.        (full – 2012)


Lower levels of cannabinoid 1 receptor mRNA in female eating disorder patients: Association with wrist cutting as impulsive self-injurious behavior.                                                                       (abst – 2012)


The role of the endocannabinoid system in eating disorders: pharmacological implications.           (abst – 2012)                          


The therapeutic potential of cannabis and cannabinoids.                    (abst – 2012)


Do deficits in brain cannabinoids contribute to eating disorders?                     (news – 2012)

Share a link for